Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Investigators at Centers for Disease Control and Prevention publish new data on immunization
October 22nd, 2008
Fresh data on immunization are presented in the report 'Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.' According to a study from the United States, "Long-term follow-up studies of populations that received recombinant hepatitis B (HB) vaccination beginning at birth are limited. Micronesian adolescents who had received 3 doses of recombinant HB vaccine (Recombivax 5 microg at birth, 2.5 microg at 2 months, 2.5 microg ug at 6 months) and tested negative for antibody to HB core antigen (anti-HBc) 2 years after primary vaccination (baseline testing) were followed up...
Source: Vaccine Weekly (2008-10-22)
|
